Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2016

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

Domaines

Cancer

Dates et versions

hal-02350496 , version 1 (06-11-2019)

Identifiants

Citer

Damien Destouches, Maha Sader, Stephane Terry, Charles Marchand, Pascale Maillé, et al.. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget, 2016, 7 (43), ⟨10.18632/oncotarget.8043⟩. ⟨hal-02350496⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More